Omeros | OMER - Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
Adma Biologics USD 193.58M 124.25M 2026-03
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Cytokinetics USD 247.21M 868.77M 2026-03
Gilead Sciences USD 20.86B 1.27B 2026-03
Heron Therapeutics USD 140.64M 975K 2025-12
Immunic USD 0 0 2024-06
Insmed USD 542.22M 1.25M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
MacroGenics USD 70M 256K 2025-12
Omeros USD 403.72M 27.2M 2024-06
Pacira USD 367.66M 4.53M 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Rockwell Medical USD 8.65M 89K 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12
Xoma USD 94.38M 7.82M 2025-09